Better Growth Stock: Abbott vs. AbbVie
Abbott Laboratories (NYSE: ABT) and (NYSE: ABBV) share a common past. About a decade ago, Abbott spun out its pharmaceuticals business into a separate company to create AbbVie. Since then, both companies have grown revenue and net income in the triple digits. At the same time, they've steadily increased dividends year after year, offering shareholders passive income growth too.
After last year's stock market gains, you may be looking toward the next bull market and aiming to prepare by scooping up growth stocks. Both Abbott and AbbVie could fit into your strategy. But, if you could only buy one, which should you choose? Let's find out which one of these healthcare companies makes the better growth stock to buy now.
Image source: Getty Images.
Source Fool.com
AbbVie Inc. Stock
The stock is an absolute favorite of our community with 21 Buy predictions and no Sell predictions.
As a result the target price of 174 € shows a slightly positive potential of 14.34% compared to the current price of 152.18 € for AbbVie Inc..
